Skip to main content
BrainCited
Figure 4

Deskripsi

Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.

More Figures from This Paper

Experimental results examining from metabolic dysregulation to neurodegenerative pathology, with data points illustrating key findings related to type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

Figure 1

Experimental results examining from metabolic dysregulation to neurodegenerative pathology, with data points illustrating key findings related to type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

chart
Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions.

Figure 2

Statistical analysis from research investigating from metabolic dysregulation to neurodegenerative pathology, comparing treatment groups and control conditions.

chart
Measured parameters from a study evaluating from metabolic dysregulation to neurodegenerative pathology, contributing to the overall assessment of type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

Figure 3

Measured parameters from a study evaluating from metabolic dysregulation to neurodegenerative pathology, contributing to the overall assessment of type 2 Diabetes (T2D) and Alzheimer's Disease (AD) share common risk factors that can be seen through T2D nearly doub.

chart

Figure 4

Chart
987 × 543px · 195,8 KB

Source Paper

From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer's disease.

Metabolic brain disease (2025)

PMID: 41003796

DOI: 10.1007/s11011-025-01700-z

Cite This Figure

![Figure 4: Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.](https://pdfs.citedhealth.com/figures/41003796/239.png)

> Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." *Metabolic brain disease*, 2025. PMID: [41003796](https://pubmed.ncbi.nlm.nih.gov/41003796/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/41003796/239.png" alt="Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions." />
  <figcaption>Figure 4. Graphical representation of outcomes in a study of from metabolic dysregulation to neurodegenerative pathology, highlighting trends observed across experimental conditions.<br>  Source: Ahmad Raza et al. "From metabolic dysregulation to neurodegenerative pathology: the role of hypergl." <em>Metabolic brain disease</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/41003796/">41003796</a></figcaption>
</figure>

Bukti Terkait

C
Taurine untuk Oxidative Stress & Neuroinflammation

Peringkat C · 6 studi